GlassScriptPhysician profile
Stephen J Seffense
NPI 1336158005
$1,547.50
in general payments reported to CMS, 2019-2025
16 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $24.58 · 2021: $137 · 2022: $69.74 · 2023: $159 · 2024: $352 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616 · Travel and Lodging: $9.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.87 |
| Travel and Lodging | $9.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $628.01 | 2019 | |
| Endomagnetics LTD | $411.31 | 2023-2024 | Magseed, Magtrace |
| Intuitive Surgical, INC. | $99.01 | 2021 | |
| Elucent Medical | $81.26 | 2024-2025 | |
| Smith+Nephew, INC. | $62.84 | 2020-2024 | Stravix |
| Merck Sharp & Dohme LLC | $37.63 | 2023-2025 | Keytruda, Lynparza |
| Abbvie INC. | $35.04 | 2021-2022 | |
| Ethicon US, LLC | $31.55 | 2019 | |
| Ambu INC. | $27.36 | 2022 | |
| Ge Healthcare | $26.37 | 2025 | |
| Endogastric Solutions, INC | $24.44 | 2022 | |
| Portola Pharmaceuticals, LLC | $21.56 | 2019 | |
| Integra Lifesciences Corporation | $19.81 | 2023 | Integra, Omnigraft, Surgimend |
| Polynovo North America LLC | $17.97 | 2024 | Novosorb Btm |
| Boston Scientific Corporation | $13.83 | 2024 | Spyglass Discover |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolder Surgical LLC | $9.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Seffense listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.